Overview

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

Status:
RECRUITING
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess efficacy of YZJ-1139 for 28 days in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Phase:
PHASE3
Details
Lead Sponsor:
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Treatments:
Zolpidem